This partnership goes beyond diagnostics and research, extending towards targeted therapies for patients tailored to their unique genetic makeup ACCRA, Ghana, April 29, 2025/APO Group/ —...
Revna Biosciences’ accreditation encompasses an extensive array of human sample tests, including those involving urine, swabs, blood, bone marrow, tissue samples, and plasma ACCRA, Ghana, April...
The innovative precision medicine company expands its focus to address unmet oncology needs ACCRA, Ghana, October 31, 2023/APO Group/ — Revna Biosciences (RevnaBio) (www.RevnaBio.com), a leading...